SIGA Technologies, Inc
- Biotech or pharma, therapeutic R&D
SIGA Technologies is a commercial-stage pharmaceutical company focused on Health Security. Our lead product TPOXX® (USAN tecovirimat, ST-246®), available in oral and intravenous formulations, is approved by the U.S. FDA for the treatment of smallpox.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}